ECKERT & ZIEGLER STRAHLEN- UND MEDIZINTECHNIK AG

(EUZ)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization1 9819231 953866--
Enterprise Value (EV)1 9228351 885810858855
P/E ratio 44,4x40,4x56,7x28,0x25,4x19,5x
Yield 0,89%1,00%0,53%1,20%1,20%1,20%
Capitalization / Revenue 5,50x5,24x10,8x4,22x3,84x3,27x
EV / Revenue 5,17x4,74x10,4x3,95x3,80x3,23x
EV / EBITDA 21,4x17,9x-15,5x15,2x12,1x
Price to Book ------
Nbr of stocks (in thousands) 20 59020 59020 75620 756--
Reference price (EUR) 47,744,894,141,741,741,7
Announcement Date 03/31/202003/26/202103/30/2022---
1 EUR in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales1 178176180205226265
EBITDA1 43,146,7-52,156,670,4
Operating profit (EBIT)1 32,135,747,442,546,660,4
Operating Margin 18,0%20,3%26,3%20,7%20,7%22,8%
Pre-Tax Profit (EBT)1 31,232,746,441,445,659,3
Net income1 22,022,934,530,733,844,1
Net margin 12,3%13,0%19,1%15,0%15,0%16,7%
EPS2 1,071,111,661,491,642,14
Dividend per Share2 0,430,450,500,500,500,50
Announcement Date 03/31/202003/26/202103/30/2022---
1 EUR in Million
2 EUR
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt1 ------
Net Cash position1 59,088,668,155,77,9010,2
Leverage (Debt / EBITDA) -1,37x-1,90x--1,07x-0,14x-0,14x
Free Cash Flow1 33,227,95,00-19,4-37,512,7
ROE (Net Profit / Equities) 16,9%16,0%-14,1%11,1%13,1%
Shareholders' equity1 130143-218305337
ROA (Net Profit / Asset) ------
Assets1 ------
Book Value Per Share ------
Cash Flow per Share ------
Capex1 7,258,9128,956,875,028,9
Capex / Sales 4,06%5,06%16,0%27,7%33,3%10,9%
Announcement Date 03/31/202003/26/202103/30/2022---
1 EUR in Million
Previous periodNext period
Estimates
Key data
Capitalization (EUR) 865 536 709
Capitalization (USD) 900 475 145
Net sales (EUR) 180 435 000
Net sales (USD) 187 718 477
Number of employees 866
Sales / Employee (EUR) 208 355
Sales / Employee (USD) 216 765
Free-Float 67,1%
Free-Float capitalization (EUR) 580 364 096
Free-Float capitalization (USD) 603 791 194
Avg. Exchange 20 sessions (EUR) 4 369 528
Avg. Exchange 20 sessions (USD) 4 545 910
Average Daily Capital Traded 0,50%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA